Registration Information

There is no fee for this activity, however you will be asked to provide credit card information to guarantee your reservation. Credit cards will be charged a one-time $25 fee ONLY if you do not attend or do not cancel your registration by January 23, 2019.

Registration is granted on a first-come, first-served basis as space is limited. We encourage you to register early and reserve your space, as we cannot guarantee that we can accommodate onsite registration.

Goal of the Summit:

To improve the diagnosis and treatment of patients with myelodysplastic syndrome and acute myeloid leukemia. Participants will actively engage in multidisciplinary, small-group activities covering the following:

• Risk stratification

• Diagnostic testing

• The role of transplants

• Alternative to 7+3

Summit Faculty:

Jessica Altman, MD, Chair

Associate Professor of Medicine Hematology/Oncology

Northwestern University

Feinberg School of Medicine

Chicago, Illinois

Linda J. Burns, MD

Medical Director, Medical Services

National Marrow Donor Program (NMDP)/Be The Match

Senior Scientific Director

Center for International Blood and Marrow Transplant Research

Minneapolis, Minnesota

AnneMarie Block, PhD, FACMG

Laboratory Director, Cytogenetics Lab

Department of Pathology and Laboratory Medicine

Associate Professor of Oncology

Roswell Park Comprehensive Cancer Center

Buffalo, New York

Robert Paul Hasserjian, MD

Associate Pathologist

Massachusetts General Hospital

Associate Professor of Pathology

Harvard Medical School

Boston, Massachusetts

Michael Linden, MD, PhD

Associate Professor

Department of Laboratory

Medicine and Pathology

University of Minnesota

Minneapolis, Minnesota

Kirsten Roblee, BSN, RN, OCN

The James Cancer Hospital and Solove Research Institute

Columbus, Ohio

B. Douglas Smith, MD

Professor of Oncology

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University School of Medicine

Baltimore, Maryland